Nrg Oncology
Clinical trials sponsored by Nrg Oncology, explained in plain language.
-
Blood test may decide who needs chemo after colon cancer surgery
Disease control Recruiting nowThis study looks at whether a blood test that finds tiny bits of tumor DNA (ctDNA) after colon cancer surgery can help doctors choose the right chemotherapy. About 1,900 people with stage III colon cancer will join. The goal is to see if using this test leads to better cancer con…
Phase: PHASE2, PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 17, 2026 04:35 UTC
-
Shorter maintenance therapy may be just as effective for ovarian cancer
Disease control Recruiting nowThis study tests whether taking the drug olaparib for one year works as well as taking it for two years to keep ovarian cancer from coming back. Participants have a specific genetic type of advanced ovarian cancer (BRCA mutation or HRD positive) and have already responded to init…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 17, 2026 04:33 UTC
-
Radiation-Free breast cancer treatment shows promise in major trial
Disease control Recruiting nowThis study is for women with stage I, hormone-sensitive breast cancer. It compares two treatments after lumpectomy: hormone therapy alone versus hormone therapy plus radiation. The goal is to see if skipping radiation is just as effective at preventing cancer from coming back in …
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 17, 2026 04:17 UTC
-
New combo radiation therapy aims to boost survival in advanced lung cancer
Disease control Recruiting nowThis study tests whether adding a precise, high-dose radiation treatment (SBRT) to the tumor before standard chemoradiation and immunotherapy can help people with locally advanced lung cancer live longer. About 474 adults whose lung cancer has spread to nearby lymph nodes but can…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 17, 2026 04:16 UTC
-
New radiation approach may protect memory in lung cancer patients with brain tumors
Disease control Recruiting nowThis study compares two types of radiation for people with small cell lung cancer that has spread to the brain. One method uses a precise, high-dose beam to each tumor, while the other treats the whole brain but avoids the memory center. The goal is to see which approach better p…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 17, 2026 04:15 UTC
-
New proton radiation trial aims to extend survival in advanced cancer patients
Disease control Recruiting nowThis study tests if a precise type of proton radiation (pCSI) can help people with breast or lung cancer that has spread to the fluid-filled space around the brain and spinal cord live longer than standard x-ray radiation. About 115 participants will be randomly assigned to one o…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Smart drugs take on rare salivary gland cancer in new trial
Disease control Recruiting nowThis study tests whether newer targeted therapies can better control advanced salivary gland cancer that has spread or cannot be removed. About 146 adults with HER2-positive or HER2-low tumors will receive either standard chemo plus trastuzumab or one of two antibody-drug conjuga…
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Could 5 radiation doses replace 45 for prostate cancer?
Disease control Recruiting nowThis study compares a new, shorter radiation treatment (5 sessions over 2 weeks) to the standard longer treatment (20-45 sessions over 4-9 weeks) for men with high-risk prostate cancer. The goal is to see if the shorter approach is just as effective at preventing the cancer from …
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Brain tumor study: is radiation after surgery worth it?
Disease control Recruiting nowThis study looks at whether giving radiation therapy after complete removal of a grade II meningioma (a type of brain tumor) helps keep the tumor from coming back, compared to just watching and waiting. About 163 people with newly diagnosed, fully removed tumors will be randomly …
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 15, 2026 11:52 UTC
-
Can higher radiation doses beat pancreatic cancer?
Disease control Recruiting nowThis study tests whether giving a higher dose of radiation can help people with locally advanced pancreatic cancer live longer. Participants must have already had 4-6 months of chemotherapy. The trial compares higher-dose radiation to standard care (more chemo, observation, or lo…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Radiation boosts immunotherapy in advanced liver cancer? new trial aims to find out
Disease control Recruiting nowThis study is for people with advanced liver cancer that has spread to nearby blood vessels. It compares standard immunotherapy drugs alone versus immunotherapy plus precise, high-dose radiation (SBRT) to the liver tumor. The goal is to see if adding radiation helps patients live…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New study tests if smaller neck surgery can spare shoulder function in oral cancer patients
Disease control Recruiting nowThis study compares two types of surgery for early-stage oral cavity cancer: a newer, less invasive approach called sentinel lymph node biopsy that removes only a few key lymph nodes, versus the standard elective neck dissection that removes many lymph nodes. The goal is to see i…
Phase: PHASE2, PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New drug combo aims to stop prostate cancer spread in high-risk patients
Disease control Recruiting nowThis study tests whether adding a drug called apalutamide to standard hormone therapy and radiation can keep prostate cancer from spreading in people whose cancer was found in lymph nodes after prostate removal surgery. About 586 participants will be randomly assigned to get eith…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Could adding chemo help some breast cancer patients avoid recurrence?
Disease control Recruiting nowThis study is for premenopausal women with a common type of early-stage breast cancer (ER-positive, HER2-negative) that has a low risk of coming back. It compares two treatment plans: hormone therapy alone versus hormone therapy plus chemotherapy. The goal is to see if adding che…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New radiation method could spare heart and lungs in esophageal cancer patients
Disease control Recruiting nowThis study compares two radiation techniques for people with stage I to IVA esophageal cancer: proton beam therapy (PBT) and intensity modulated photon radiotherapy (IMRT). The goal is to see which one helps patients live longer and causes fewer serious heart and lung side effect…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
New combo therapy aims to stall advanced kidney cancer without surgery
Disease control Recruiting nowThis study is for people with advanced kidney cancer that has spread and cannot be removed by surgery. It tests whether adding a precise, high-dose form of radiation (SABR) to the main tumor, alongside standard immunotherapy drugs, can better control the cancer and delay its grow…
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 06, 2026 16:00 UTC
-
Can fewer radiation blasts beat bladder cancer just as well?
Disease control Recruiting nowThis study compares two ways of giving radiation therapy for muscle-invasive bladder cancer. One group gets the usual number of radiation sessions (hypofractionation) and the other gets even fewer, higher-dose sessions (ultra-hypofractionation), both combined with standard chemot…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 04, 2026 16:18 UTC
-
10-year colonoscopy interval tested for low-risk polyp patients
Prevention Recruiting nowThis study looks at whether people who had 1 or 2 small, non-cancerous polyps removed can safely wait 10 years for their next colonoscopy instead of the usual 5 years. About 9,500 adults aged 45-69 will be randomly assigned to have a colonoscopy at 5 and 10 years or only at 10 ye…
Phase: NA • Sponsor: NRG Oncology • Aim: Prevention
Last updated May 13, 2026 15:58 UTC
-
Could a less invasive surgery prevent ovarian cancer in High-Risk women?
Prevention Recruiting nowThis study looks at two surgeries for women with BRCA1 gene changes who are at high risk for ovarian cancer. One surgery removes only the fallopian tubes, while the other removes both tubes and ovaries. The goal is to see if removing just the tubes works nearly as well at prevent…
Phase: NA • Sponsor: NRG Oncology • Aim: Prevention
Last updated Apr 29, 2026 15:04 UTC
-
Brain games tested to clear chemo fog in breast cancer survivors
Symptom relief Recruiting nowThis study tests if computerized brain training can improve memory and thinking problems in breast cancer survivors. About 386 women who had breast cancer and report mental fogginess will be randomly assigned to either a brain training program or a placebo. The goal is to see if …
Phase: NA • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated May 17, 2026 04:35 UTC
-
New drug aims to ease painful mouth sores for head and neck cancer patients
Symptom relief Recruiting nowThis study tests whether adding BMX-001 to standard care can reduce severe mouth sores caused by chemoradiation in head and neck cancer patients. About 98 participants will receive either BMX-001 or a placebo alongside their usual treatment. The goal is to improve quality of life…
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated May 17, 2026 04:33 UTC
-
New study aims to prevent leg swelling in endometrial cancer surgery
Symptom relief Recruiting nowThis study looks at 428 people with stage I endometrial cancer who are having a hysterectomy. It compares two ways to check if cancer has spread to lymph nodes: the standard method (removing many lymph nodes) versus a newer method (using dye to find and remove only the key nodes)…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated May 17, 2026 04:30 UTC
-
Brain tumor radiation showdown: one big dose or three smaller ones?
Symptom relief Recruiting nowThis study tests whether giving radiation in three smaller doses (fractionated SRS) is better than a single large dose (standard SRS) for treating cancer that has spread to the brain. About 269 adults with certain cancers (like lung, breast, or melanoma) will be enrolled. The goa…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated May 17, 2026 04:16 UTC
-
Mindfulness apps vs. live zoom: which eases Post-Cancer depression?
Symptom relief Recruiting nowThis study tests two online mindfulness programs for younger breast cancer survivors (diagnosed at or before age 50) who have finished primary treatment and feel depressed. One program is a live class over Zoom, the other is a self-paced app. The goal is to see which approach bet…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated May 14, 2026 12:06 UTC
-
Phone support eases cancer treatment side effects
Symptom relief Recruiting nowThis study tests two ways to help people on oral cancer drugs manage symptoms and emotional distress. One method uses automated phone calls to track symptoms and alert doctors. The other adds a self-help handbook and counseling for those feeling anxious or sad. The goal is to red…
Phase: NA • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated May 13, 2026 15:58 UTC